161 results
424B3
CYDY
CytoDyn Inc.
29 Jan 24
Prospectus supplement
5:22pm
, the “Company Policies”).
Section 2.4Time Commitment. During the Term, the Executive shall use Executive’s best efforts to promote the interests
8-K
EX-10.1
CYDY
CytoDyn Inc.
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
Commitment. During the Term, the Executive shall use Executive’s best efforts to promote the interests of the Company (including its subsidiaries
424B3
CYDY
CytoDyn Inc.
22 Nov 23
Prospectus supplement
12:16pm
(collectively, the “Company Policies”).
Section 2.4 Time Commitment. During the Term, the Executive shall use Executive’s best efforts to promote
8-K
EX-10.1
CYDY
CytoDyn Inc.
21 Nov 23
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
5:15pm
pertaining to procedures, rules, and regulations, as currently in effect (collectively, the “Company Policies”).
Section 2.4Time Commitment. During
424B3
8ph3 63vj
24 Oct 23
Prospectus supplement
6:01am
424B3
qirilp54v5t q8
10 Oct 23
Prospectus supplement
6:02pm
POS AM
4v1afczclggob
2 Oct 23
Prospectus update (post-effective amendment)
5:15pm
424B3
5oc0c9
11 Jul 23
Prospectus supplement
5:28pm
UPLOAD
lbpkkj
14 Dec 21
Letter from SEC
12:00am
8-K
EX-10.1
lq5wkw
23 Nov 21
Unregistered Sales of Equity Securities
5:15pm